Michael Eckhoff

Michael Eckhoff is a seasoned professional in regulatory affairs and analytical sciences, currently serving as Sr. Director of Regulatory Affairs CMC at Omeros Corporation since May 2022. Prior to this role, Michael held various positions at Acorda Therapeutics, progressing from Director to Sr. Director of CMC Regulatory Affairs between April 2011 and April 2022. Michael's experience also includes serving as Senior Director of Analytical Sciences at Penwest Pharmaceuticals and as Director of Analytics at CuraGen Corporation. Michael holds a PhD in Analytical Chemistry from the University of Cincinnati and a BS in Chemistry from Kent State University.